NCT06586905View on ClinicalTrials.gov

A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario.

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2026

Conditions
SyphilisTreponema Pallidum
Interventions
DEVICE

Medical Device

Multiplo Complete Syphilis (TP/nTP) Antibody Test

Trial Locations (1)

K1N 1B3

Sexual Health Clinic, Ottawa

Sponsors
All Listed Sponsors
collaborator

Public Health Agency of Canada (PHAC)

OTHER_GOV

lead

MedMira Laboratories Inc.

INDUSTRY

NCT06586905 - A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario. | Biotech Hunter | Biotech Hunter